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Abstract: Different crude methanolic and chloroform extracts of Withania somnifera leaves, and column fractions of the methanolic
extract, were tested in vivo for antimalarial activity on Swiss albino male mice. Each mouse in the study was infected intraperitoneally
with 0.2 mL of blood containing 106–107 infected erythrocytes taken from mice previously infected with chloroquine-sensitive
Plasmodium berghei. The extracts were given to the infected mice intraperitoneally starting from 3 h following inoculation. Antimalarial
activity was evaluated by taking blood smears on day 4. The results revealed that column fractions of methanolic extract obtained from
leaves of Withania somnifera showed significantly improved suppression of parasitemia at lower doses compared to the crude extracts.
Reduction of parasitemia by 44% and 57% was observed at doses of 200 and 300 mg/kg body weight, respectively, by column fractions
of methanolic crude extract.
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1. Introduction
Malaria is one of the parasitic infections that cause
enormous medical, economic, and emotional burden in
the world. It has been estimated that more than 300–500
million people are affected by malaria throughout the
world (1). In Sub-Saharan Africa alone, an estimated 0.9–
2.3 million annual child deaths are attributed to malaria
(2). However, these estimates are changing, as a recent
report by the World Health Organization indicated that
promising malaria prevention and control measures, such
as insecticide-treated mosquito nets and indoor spraying
with residual insecticides, have led to a significant drop
of the mortality rate by 25% since 2000 (3). On the
other hand, resistance of the vector mosquitoes to the
current insecticides and the emergence of resistance by
Plasmodium species to widely used antimalarial drugs,
such as chloroquine, have made malaria control and
treatment much more difficult (4), leading to the use of
traditional methods of treatment (5). Recently, the use of
natural products in treating various ailments is gaining
attention, as the synthetic drugs are causing undesirable
side effects (6) and microbes are showing resistance to
most of the currently available antibiotics (7).
It is estimated that more than 75% of the world’s
population relies on medicinal plants for treatment of
* Correspondence: zerihuntm@yahoo.com

various ailments. There are hundreds of clinically useful
prescription drugs that are derived from plants, and about
74% of them came to the attention of the pharmaceutical
industry because of their use in traditional medicine (8,9).
Different parts of the studied plant, Withania somnifera
(also called ashwagandha, Indian ginseng, and winter
cherry), have been reported to have antimalarial activities
both in vivo and in vitro (10). Therefore, the aim of the
present study was to evaluate and improve the reported
in vivo antimalarial activity of the plant through testing
different column fractions of the crude extract from its
leaves.
2. Materials and methods
2.1. Plant material and extraction procedure
Fresh leaves of W. somnifera were collected from Zeway
(160 km south of Addis Ababa). Identity of the plant
material was confirmed at the National Herbarium, Addis
Ababa University Department of Biology. Fresh leaves of
W. somnifera were ground using a grinding mill (Straub
Model 4E, USA). The powdered materials obtained were
extracted first with chloroform and then with methanol
by shaking overnight on an orbital shaker (GFL Model
3020, Germany). The extracts were filtered through
cotton and then through Whatman filter paper, and the
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organic solvents were removed from the filtrate by rotary
evaporator (BUCHI RE 121, Switzerland). The obtained
crude extracts were kept in deep freeze until used for the
test.
2.2. Column separation of crude extracts
The methanolic crude extract was fractionated by means
of column chromatography using silica gel (60–120 mesh)
and eluted with chloroform, then subsequently eluted
with chloroform containing increasing concentrations of
methanol. Fractions were collected and monitored by thin
layer chromatography (TLC), and fractions with similar
TLC profiles were combined and tested for activity.
2.3. Antimalarial tests
In vivo antimalarial testing was carried out using the
classic 4-day suppressive test against P. berghei (11). Fiveto seven-week-old Swiss albino mice weighing 24–31 g
were obtained for the study from the animal house of the
Department of Biology of Addis Ababa University. The
mice were fed with standard mice pellet and given water
ad libitum. The test animals were put randomly into 5
groups, each containing 5 mice. Blood samples taken from
donor mice previously infected with chloroquine-sensitive
P. berghei with parasitemia of about 20% were diluted
with physiological saline so that 0.2 mL contained 106–107
infected erythrocytes. Each mouse used in the study was
infected intraperitoneally by using a hypodermic needle
fitted to a 1-mL syringe. The test extracts in the proportion
of 200 or 300 mg/kg were administered intraperitoneally.
Mice in the first group of each test were the negative control
(NC) and were given the vehicle (3% w/v Tween 80) (11).
To evaluate the safety of the extracts and rule out acute
toxicity, both crude and column fractions were given at
doses of 1000 and 500 mg/kg, respectively, to noninfected
mice following the procedure of Tchoumbougnang et al.
(12) with minor modifications. For the 4-day suppressive
test, the extracts were given once daily continuously for
4 days starting from day 0 to day 3, and percentage of
parasitemia was recorded on day 4 by collecting blood
samples from the tail using the Giemsa-stained thin
blood smears technique, following the procedure used
by Satyavivad et al. (11). Each experiment was done
in duplicate, and results obtained from the study are
presented as mean plus or minus standard error of the
mean (M ± SEM). Statistical significance was determined
by one-way ANOVA and Scheffé’s post hoc test using
SPSS 13.0. Student’s paired t-test was used to compare
parameters within groups. For all the data obtained,
%Suppression =

statistical significance was set at P = 0.05. Percentage of
parasitemia and percentage of suppression were calculated
using the following formulas, proposed by Li et al. (13)
and Devi et al., respectively (14).
3. Results and discussion
Results from the safety tests of the extracts showed no
visible toxic effects up to 1000 and 500 mg/kg for the crude
extracts and column fractions, respectively. Examination of
thin blood smears from mice of each group showed a lower
percentage of parasitemia in all the mice administered
with the extracts compared to the negative control groups.
Chloroform extracts of leaves of W. somnifera did not
induce significant in vivo suppression on P. berghei in mice
at different tested doses (Table 1) and therefore were not
chromatographed. However, this result is in contradiction
with the in vitro results reported by Bogale and Petros
(15) on Plasmodium falciparum, which showed significant
antimalarial activity at IC50 = 2.04 µg/kg in vitro. This
could be because of the fact that antiplasmodial activity of
plants in vitro may not necessarily imply the same activity
in vivo; rather, compounds may either act as prodrugs,
which must undergo metabolic activity, or as febrifuges or
immunomodulators (16).
On the other hand, results obtained from in vivo
antimalarial activity of methanolic extract of the leaves
of W. somnifera were in agreement with the reported
antimalarial activities of the plant in vitro (15). In addition,
the observed antimalarial activity of methanolic crude
extract of leaves of W. somnifera was improved through
fractionation; the highest suppressive effect shown was
57% by fraction F3 (Table 2). This observation was in
accordance with the activity reported in vitro (15).
The 2 fractions (F2 and F3) showed significant
suppressive effect (P < 0.01 and P < 0.001, respectively) at
a dose of 200 mg/kg. On the other hand, the first fraction
of the extract (F1) showed no significant effect on the
parasitemia level of the treated mice as compared to the
negative control mice (Table 2). In all the groups treated
with the fractions, a drop in packed cell volume and
differences in body weight were observed. However, the
suppression seen by F2 and F3 significantly improved the
activities observed from crude methanolic and chloroform
extracts. The level of suppression induced by the third
fraction (F3) at a dose of 300 mg/kg (Table 2) is within the
limits of what may be considered good antimalarial activity

Parasitemia in control – Parasitemia in study group
# 100
Parasitemia in control

Number of infected red blood cells
%Parasitemia = Number of uninfected red blood cells – Number of infected red blood cells # 100
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Table 1. Activity of extracts from leaves of W. somnifera against P. berghei in mice.

Extract

Methanol extract

Chloroform extract

Daily dose (mg/kg)
NC
500
750
900
NC
500
750
900

Antimalarial activity
% Parasitemia ± SEM

% Suppression

9.88 ± 0.82
8.83 ± 1.05
5.61 ± 0.43 *
4.61 ± 0.24 **
10.0 ± 0.71
8.06 ± 0.86
7.90 ± 0.52
8.65 ± 1.16

00.00
10.63
43.20
53.34
00.00
18.42
17.63
14.00

Key: * = P < 0.01; ** = P < 0.001. All tests were compared against the negative control (NC).

Table 2. Activity of column fractions of methanolic crude extracts obtained from leaves of W. somnifera against P. berghei in mice.

Fractions

F1
F2
F3

Daily dose (mg/kg/day)
NC
200
300
200
300
200
300

Antimalarial activity
% Parasitemia ± SEM
9.75 ± 0.82
9.37 ± 1.05
nt
7.12 ± 0.31 *
6.88 ± 0.1.5 *
8.06 ± 0.86
4.25 ± 0.30 **

% Suppression
00.00
04.45
nt
28.14
29.00
44.33
57.00

Key: * = P < 0.01; ** = P < 0.001; nt = not tested. All tests were compared against the negative control (NC).

for a medicinal plant extract, which is a suppression of
≥50% at a dose of 250 mg/kg (17). This suppression is
also comparable to the reported antimalarial activity of
Cassia occidentalis root bark and Phyllanthus niruri, which
produced 60% suppression of parasitemia in vivo (18),
and that of the essential oil of Cymbopogon citratus, which
produced 62.1% suppression at 200 mg/kg in vivo (12).
The antimalarial activity observed for the fractions may be
an indication of a nonsynergistic effect of the compounds
present in the crude extracts. Therefore, the suppression
induced by the extracts might be associated with the
presence of chemical ingredients that have antimalarial
properties. Biologically active chemical constituents, such
as alkaloids, have been reported from different parts of the
plant (19). Therefore, the observed antimalarial activity
could be associated with some of the alkaloids reported
from the plant, as alkaloids such as quinine are known for
their antimalarial activities. The therapeutic value of the
plant has also been extensively reported. Recently, this plant
was demonstrated to possess strong antifungal activity and
was found to be effective against murine aspergillosis, and

it possesses strong antibacterial properties against various
pathogens, including Salmonella typhimurium (20).
In conclusion, the present study has demonstrated that
the antimalarial activity of the plant could be significantly
improved through fractionation of the methanolic crude
extract of its leaves. The third fraction obtained from
the methanolic crude extract showed 57% suppression
of parasitemia in P. berghei-infected mice at a dose of
300 mg/kg/day. The plant may contain an undiscovered
antimalarial active ingredient that could serve as a template
for the production of relatively inexpensive antimalarial
drugs. Therefore, it is worth conducting a bioassay-guided
fractionation and isolation of the active compound(s) and
a detailed study of their activities both in vivo and in vitro.
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